Neovacs acquires Interferon Alpha manufacturing technology from AMEGABIOTECH
16-Nov-2016
- France
AMEGABIOTECH is a leading global producer of IFNα protein and a long term supplier of Neovacs, particularly for its on-going Phase IIb study of IFNα Kinoid in Lupus. Their product is recognized by the international biotechnology and pharmaceutical industry for the quality of its technological manufacturing, which also meets all relevant international standards for GMP (Good manufacturing Practice).
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.